Selected research
Market Structure
Global Anti-dementia Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-dementia Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Anti-dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-dementia Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-dementia Drugs include Eisai Inc., Forest Laboratories, Inc, Niksan Pharmaceutical, Pfizer Inc, Reddy's Laboratories, Anhui Taienkang Pharmaceutical Co., Ltd., Chengdu Tongde Pharmaceutical Co., Ltd., Disa Pharmaceutical Group Co., Ltd. and Jiangsu Hausen Pharmaceutical Group Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Anti-dementia Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-dementia Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-dementia Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-dementia Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-dementia Drugs Segment by Company
Eisai Inc.
Forest Laboratories, Inc
Niksan Pharmaceutical
Pfizer Inc
Reddy's Laboratories
Anhui Taienkang Pharmaceutical Co., Ltd.
Chengdu Tongde Pharmaceutical Co., Ltd.
Disa Pharmaceutical Group Co., Ltd.
Jiangsu Hausen Pharmaceutical Group Co., Ltd.
Jinri Pharmaceutical (China) Co., Ltd.
Livzon Group Livzon Pharmaceutical Factory
Shandong Luoxin Pharmaceutical Group Co., Ltd.
Shaoxing Jingxin Pharmaceutical Co., Ltd.
Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
Sichuan Xinston Pharmaceutical Co., Ltd.
Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.
Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.
Yueyang Xinhuada Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd.
Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Zhejiang Yixin Pharmaceutical Co., Ltd.
Zhien Biotechnology Co., Ltd.
Anti-dementia Drugs Segment by Type
Donepezil
Galantamine
Rivastigmine
Memantine
Other
Anti-dementia Drugs Segment by Application
Clinic
Hospital
Pharmacy
Other
Anti-dementia Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-dementia Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-dementia Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-dementia Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Anti-dementia Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-dementia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-dementia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Anti-dementia Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Anti-dementia Drugs Industry Trends
Table 2. Anti-dementia Drugs Industry Drivers
Table 3. Anti-dementia Drugs Industry Opportunities and Challenges
Table 4. Anti-dementia Drugs Industry Restraints
Table 5. Global Anti-dementia Drugs Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Anti-dementia Drugs Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Anti-dementia Drugs Sales by Manufacturers (K Units) & (2021-2026)
Table 8. Global Anti-dementia Drugs Sales Market Share by Manufacturers
Table 9. Global Anti-dementia Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026)
Table 10. Global Anti-dementia Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Anti-dementia Drugs Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Anti-dementia Drugs Manufacturers, Product Type & Application
Table 13. Global Anti-dementia Drugs Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Anti-dementia Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Donepezil
Table 17. Major Manufacturers of Galantamine
Table 18. Major Manufacturers of Rivastigmine
Table 19. Major Manufacturers of Memantine
Table 20. Major Manufacturers of Other
Table 21. Global Anti-dementia Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units)
Table 22. Global Anti-dementia Drugs Sales by Type (2021-2026) & (K Units)
Table 23. Global Anti-dementia Drugs Sales by Type (2027-2032) & (K Units)
Table 24. Global Anti-dementia Drugs Sales Market Share by Type (2021-2026)
Table 25. Global Anti-dementia Drugs Sales Market Share by Type (2027-2032)
Table 26. Global Anti-dementia Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units)
Table 27. Global Anti-dementia Drugs Revenue by Type (2021-2026) & (K Units)
Table 28. Global Anti-dementia Drugs Revenue by Type (2027-2032) & (K Units)
Table 29. Global Anti-dementia Drugs Revenue Market Share by Type (2021-2026)
Table 30. Global Anti-dementia Drugs Revenue Market Share by Type (2027-2032)
Table 31. Major Manufacturers of Clinic
Table 32. Major Manufacturers of Hospital
Table 33. Major Manufacturers of Pharmacy
Table 34. Major Manufacturers of Other
Table 35. Global Anti-dementia Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units)
Table 36. Global Anti-dementia Drugs Sales by Application (2021-2026) & (K Units)
Table 37. Global Anti-dementia Drugs Sales by Application (2027-2032) & (K Units)
Table 38. Global Anti-dementia Drugs Sales Market Share by Application (2021-2026)
Table 39. Global Anti-dementia Drugs Sales Market Share by Application (2027-2032)
Table 40. Global Anti-dementia Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units)
Table 41. Global Anti-dementia Drugs Revenue by Application (2021-2026) & (K Units)
Table 42. Global Anti-dementia Drugs Revenue by Application (2027-2032) & (K Units)
Table 43. Global Anti-dementia Drugs Revenue Market Share by Application (2021-2026)
Table 44. Global Anti-dementia Drugs Revenue Market Share by Application (2027-2032)
Table 45. Global Anti-dementia Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units)
Table 46. Global Anti-dementia Drugs Sales by Region (2021-2026) & (K Units)
Table 47. Global Anti-dementia Drugs Sales Market Share by Region (2021-2026)
Table 48. Global Anti-dementia Drugs Sales Forecasted by Region (2027-2032) & (K Units)
Table 49. Global Anti-dementia Drugs Sales Forecasted Market Share by Region (2027-2032)
Table 50. North America Anti-dementia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 51. North America Anti-dementia Drugs Sales by Country (2021-2026) & (K Units)
Table 52. North America Anti-dementia Drugs Sales by Country (2027-2032) & (K Units)
Table 53. Europe Anti-dementia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 54. Europe Anti-dementia Drugs Sales by Country (2021-2026) & (K Units)
Table 55. Europe Anti-dementia Drugs Sales by Country (2027-2032) & (K Units)
Table 56. Asia Pacific Anti-dementia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 57. Asia Pacific Anti-dementia Drugs Sales by Country (2021-2026) & (K Units)
Table 58. Asia Pacific Anti-dementia Drugs Sales by Country (2027-2032) & (K Units)
Table 59. South America, Middle East and Africa Anti-dementia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units)
Table 60. South America, Middle East and Africa Anti-dementia Drugs Sales by Country (2021-2026) & (K Units)
Table 61. South America, Middle East and Africa Anti-dementia Drugs Sales by Country (2027-2032) & (K Units)
Table 62. Global Anti-dementia Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 63. Global Anti-dementia Drugs Revenue by Region (2021-2026) & (US$ Million)
Table 64. Global Anti-dementia Drugs Revenue by Region (2027-2032) & (US$ Million)
Table 65. Global Anti-dementia Drugs Revenue Market Share by Region (2021-2026)
Table 66. Global Anti-dementia Drugs Revenue Market Share by Region (2027-2032)
Table 67. Eisai Inc. Company Information
Table 68. Eisai Inc. Business Overview
Table 69. Eisai Inc. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 70. Eisai Inc. Anti-dementia Drugs Product Portfolio
Table 71. Eisai Inc. Recent Development
Table 72. Forest Laboratories, Inc Company Information
Table 73. Forest Laboratories, Inc Business Overview
Table 74. Forest Laboratories, Inc Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 75. Forest Laboratories, Inc Anti-dementia Drugs Product Portfolio
Table 76. Forest Laboratories, Inc Recent Development
Table 77. Niksan Pharmaceutical Company Information
Table 78. Niksan Pharmaceutical Business Overview
Table 79. Niksan Pharmaceutical Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Niksan Pharmaceutical Anti-dementia Drugs Product Portfolio
Table 81. Niksan Pharmaceutical Recent Development
Table 82. Pfizer Inc Company Information
Table 83. Pfizer Inc Business Overview
Table 84. Pfizer Inc Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 85. Pfizer Inc Anti-dementia Drugs Product Portfolio
Table 86. Pfizer Inc Recent Development
Table 87. Reddy's Laboratories Company Information
Table 88. Reddy's Laboratories Business Overview
Table 89. Reddy's Laboratories Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 90. Reddy's Laboratories Anti-dementia Drugs Product Portfolio
Table 91. Reddy's Laboratories Recent Development
Table 92. Anhui Taienkang Pharmaceutical Co., Ltd. Company Information
Table 93. Anhui Taienkang Pharmaceutical Co., Ltd. Business Overview
Table 94. Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 95. Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 96. Anhui Taienkang Pharmaceutical Co., Ltd. Recent Development
Table 97. Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
Table 98. Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview
Table 99. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 100. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 101. Chengdu Tongde Pharmaceutical Co., Ltd. Recent Development
Table 102. Disa Pharmaceutical Group Co., Ltd. Company Information
Table 103. Disa Pharmaceutical Group Co., Ltd. Business Overview
Table 104. Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 105. Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 106. Disa Pharmaceutical Group Co., Ltd. Recent Development
Table 107. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
Table 108. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
Table 109. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 110. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 111. Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Development
Table 112. Jinri Pharmaceutical (China) Co., Ltd. Company Information
Table 113. Jinri Pharmaceutical (China) Co., Ltd. Business Overview
Table 114. Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 115. Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 116. Jinri Pharmaceutical (China) Co., Ltd. Recent Development
Table 117. Livzon Group Livzon Pharmaceutical Factory Company Information
Table 118. Livzon Group Livzon Pharmaceutical Factory Business Overview
Table 119. Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 120. Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Product Portfolio
Table 121. Livzon Group Livzon Pharmaceutical Factory Recent Development
Table 122. Shandong Luoxin Pharmaceutical Group Co., Ltd. Company Information
Table 123. Shandong Luoxin Pharmaceutical Group Co., Ltd. Business Overview
Table 124. Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 125. Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 126. Shandong Luoxin Pharmaceutical Group Co., Ltd. Recent Development
Table 127. Shaoxing Jingxin Pharmaceutical Co., Ltd. Company Information
Table 128. Shaoxing Jingxin Pharmaceutical Co., Ltd. Business Overview
Table 129. Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 130. Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 131. Shaoxing Jingxin Pharmaceutical Co., Ltd. Recent Development
Table 132. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
Table 133. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
Table 134. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 135. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 136. Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Development
Table 137. Sichuan Xinston Pharmaceutical Co., Ltd. Company Information
Table 138. Sichuan Xinston Pharmaceutical Co., Ltd. Business Overview
Table 139. Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 140. Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 141. Sichuan Xinston Pharmaceutical Co., Ltd. Recent Development
Table 142. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Company Information
Table 143. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Business Overview
Table 144. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 145. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 146. Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Recent Development
Table 147. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information
Table 148. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Business Overview
Table 149. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 150. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 151. Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Development
Table 152. Yueyang Xinhuada Pharmaceutical Co., Ltd. Company Information
Table 153. Yueyang Xinhuada Pharmaceutical Co., Ltd. Business Overview
Table 154. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 155. Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 156. Yueyang Xinhuada Pharmaceutical Co., Ltd. Recent Development
Table 157. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
Table 158. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
Table 159. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 160. Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 161. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development
Table 162. Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
Table 163. Zhejiang Huahai Pharmaceutical Co., Ltd. Business Overview
Table 164. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 165. Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 166. Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Development
Table 167. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information
Table 168. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Business Overview
Table 169. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 170. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 171. Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Development
Table 172. Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
Table 173. Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview
Table 174. Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 175. Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 176. Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Development
Table 177. Zhejiang Yixin Pharmaceutical Co., Ltd. Company Information
Table 178. Zhejiang Yixin Pharmaceutical Co., Ltd. Business Overview
Table 179. Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 180. Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 181. Zhejiang Yixin Pharmaceutical Co., Ltd. Recent Development
Table 182. Zhien Biotechnology Co., Ltd. Company Information
Table 183. Zhien Biotechnology Co., Ltd. Business Overview
Table 184. Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 185. Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Product Portfolio
Table 186. Zhien Biotechnology Co., Ltd. Recent Development
Table 187. Key Raw Materials
Table 188. Raw Materials Key Suppliers
Table 189. Anti-dementia Drugs Distributors List
Table 190. Anti-dementia Drugs Customers List
Table 191. Research Programs/Design for This Report
Table 192. Authors List of This Report
Table 193. Secondary Sources
Table 194. Primary Sources
List of Figures
Figure 1. Anti-dementia Drugs Product Image
Figure 2. Global Anti-dementia Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Anti-dementia Drugs Market Size (2021-2032) & (US$ Million)
Figure 4. Global Anti-dementia Drugs Sales (2021-2032) & (K Units)
Figure 5. Global Anti-dementia Drugs Average Price (US$/Unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Anti-dementia Drugs Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Donepezil Image
Figure 9. Galantamine Image
Figure 10. Rivastigmine Image
Figure 11. Memantine Image
Figure 12. Other Image
Figure 13. Global Anti-dementia Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 14. Global Anti-dementia Drugs Sales Market Share 2021 VS 2025 VS 2032
Figure 15. Global Anti-dementia Drugs Sales Market Share by Type (2021-2032)
Figure 16. Global Anti-dementia Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units)
Figure 17. Global Anti-dementia Drugs Revenue Market Share 2021 VS 2025 VS 2032
Figure 18. Global Anti-dementia Drugs Revenue Market Share by Type (2021-2032)
Figure 19. Clinic Image
Figure 20. Hospital Image
Figure 21. Pharmacy Image
Figure 22. Other Image
Figure 23. Global Anti-dementia Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 24. Global Anti-dementia Drugs Sales Market Share 2021 VS 2025 VS 2032
Figure 25. Global Anti-dementia Drugs Sales Market Share by Application (2021-2032)
Figure 26. Global Anti-dementia Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units)
Figure 27. Global Anti-dementia Drugs Revenue Market Share 2021 VS 2025 VS 2032
Figure 28. Global Anti-dementia Drugs Revenue Market Share by Application (2021-2032)
Figure 29. North America Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 30. North America Anti-dementia Drugs Sales Market Share by Country (2021-2032)
Figure 31. U.S. Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 32. Canada Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 33. Mexico Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 34. Europe Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 35. Europe Anti-dementia Drugs Sales Market Share by Country (2021-2032)
Figure 36. Germany Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 37. France Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 38. U.K. Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 39. Italy Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 40. Netherlands Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 41. Asia Pacific Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 42. Asia Pacific Anti-dementia Drugs Sales Market Share by Country (2021-2032)
Figure 43. China Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 44. Japan Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 45. South Korea Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 46. Southeast Asia Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 47. India Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 48. Australia Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 49. South America, Middle East and Africa Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 50. South America, Middle East and Africa Anti-dementia Drugs Sales Market Share by Country (2021-2032)
Figure 51. Brazil Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 52. South Africa Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 53. Saudi Arabia Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 54. Turkey Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 55. Argentina Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 56. UAE Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 57. Egypt Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 58. Chile Anti-dementia Drugs Sales and Growth Rate (2021-2032) & (K Units)
Figure 59. Global Anti-dementia Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 60. Global Anti-dementia Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 61. North America Anti-dementia Drugs Revenue (2021-2032) & (US$ Million)
Figure 62. North America Anti-dementia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 63. Europe Anti-dementia Drugs Revenue (2021-2032) & (US$ Million)
Figure 64. Europe Anti-dementia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 65. Asia-Pacific Anti-dementia Drugs Revenue (2021-2032) & (US$ Million)
Figure 66. Asia-Pacific Anti-dementia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 67. South America, Middle East and Africa Anti-dementia Drugs Revenue (2021-2032) & (US$ Million)
Figure 68. South America, Middle East and Africa Anti-dementia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 69. Anti-dementia Drugs Value Chain
Figure 70. Manufacturing Cost Structure
Figure 71. Anti-dementia Drugs Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
Scope & coverage.
Types
- Donepezil
- Galantamine
- Rivastigmine
- Memantine
- Other
Applications
- Clinic
- Hospital
- Pharmacy
- Other
Companies covered
- Eisai Inc.
- Forest Laboratories, Inc
- Niksan Pharmaceutical
- Pfizer Inc
- Reddy's Laboratories
- Anhui Taienkang Pharmaceutical Co., Ltd.
- Chengdu Tongde Pharmaceutical Co., Ltd.
- Disa Pharmaceutical Group Co., Ltd.
- Jiangsu Hausen Pharmaceutical Group Co., Ltd.
- Jinri Pharmaceutical (China) Co., Ltd.
- Livzon Group Livzon Pharmaceutical Factory
- Shandong Luoxin Pharmaceutical Group Co., Ltd.
- Shaoxing Jingxin Pharmaceutical Co., Ltd.
- Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
- Sichuan Xinston Pharmaceutical Co., Ltd.
- Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.
- Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.
- Yueyang Xinhuada Pharmaceutical Co., Ltd.
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
- Zhejiang Jingxin Pharmaceutical Co., Ltd.
- Zhejiang Yixin Pharmaceutical Co., Ltd.
- Zhien Biotechnology Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Anti-dementia Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Anti-dementia Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Anti-dementia Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Anti-dementia Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Anti-dementia Drugs Market Dynamics
- 2.1 Anti-dementia Drugs Industry Trends
- 2.2 Anti-dementia Drugs Industry Drivers
- 2.3 Anti-dementia Drugs Industry Opportunities and Challenges
- 2.4 Anti-dementia Drugs Industry Restraints
3 Anti-dementia Drugs Market by Manufacturers
- 3.1 Global Anti-dementia Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Anti-dementia Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Anti-dementia Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Anti-dementia Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-dementia Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Anti-dementia Drugs Manufacturers, Product Type & Application
- 3.7 Global Anti-dementia Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-dementia Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-dementia Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-dementia Drugs Tier 1, Tier 2, and Tier 3
4 Anti-dementia Drugs Market by Type
- 4.1 Anti-dementia Drugs Type Introduction
- 4.1.1 Donepezil
- 4.1.2 Galantamine
- 4.1.3 Rivastigmine
- 4.1.4 Memantine
- 4.1.5 Other
- 4.2 Global Anti-dementia Drugs Sales by Type
- 4.2.1 Global Anti-dementia Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Anti-dementia Drugs Sales by Type (2021-2032)
- 4.2.3 Global Anti-dementia Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Anti-dementia Drugs Revenue by Type
- 4.3.1 Global Anti-dementia Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Anti-dementia Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Anti-dementia Drugs Revenue Market Share by Type (2021-2032)
5 Anti-dementia Drugs Market by Application
- 5.1 Anti-dementia Drugs Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Pharmacy
- 5.1.4 Other
- 5.2 Global Anti-dementia Drugs Sales by Application
- 5.2.1 Global Anti-dementia Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Anti-dementia Drugs Sales by Application (2021-2032)
- 5.2.3 Global Anti-dementia Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Anti-dementia Drugs Revenue by Application
- 5.3.1 Global Anti-dementia Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Anti-dementia Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Anti-dementia Drugs Revenue Market Share by Application (2021-2032)
6 Global Anti-dementia Drugs Sales by Region
- 6.1 Global Anti-dementia Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Anti-dementia Drugs Sales by Region (2021-2032)
- 6.2.1 Global Anti-dementia Drugs Sales by Region (2021-2026)
- 6.2.2 Global Anti-dementia Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Anti-dementia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Anti-dementia Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Anti-dementia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Anti-dementia Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Anti-dementia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Anti-dementia Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Anti-dementia Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Anti-dementia Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Anti-dementia Drugs Revenue by Region
- 7.1 Global Anti-dementia Drugs Revenue by Region
- 7.1.1 Global Anti-dementia Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Anti-dementia Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Anti-dementia Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Anti-dementia Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Anti-dementia Drugs Revenue (2021-2032)
- 7.2.2 North America Anti-dementia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Anti-dementia Drugs Revenue (2021-2032)
- 7.3.2 Europe Anti-dementia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Anti-dementia Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Anti-dementia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Anti-dementia Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Anti-dementia Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Eisai Inc.
- 8.1.1 Eisai Inc. Company Information
- 8.1.2 Eisai Inc. Business Overview
- 8.1.3 Eisai Inc. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Eisai Inc. Anti-dementia Drugs Product Portfolio
- 8.1.5 Eisai Inc. Recent Developments
- 8.2 Forest Laboratories, Inc
- 8.2.1 Forest Laboratories, Inc Company Information
- 8.2.2 Forest Laboratories, Inc Business Overview
- 8.2.3 Forest Laboratories, Inc Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Forest Laboratories, Inc Anti-dementia Drugs Product Portfolio
- 8.2.5 Forest Laboratories, Inc Recent Developments
- 8.3 Niksan Pharmaceutical
- 8.3.1 Niksan Pharmaceutical Company Information
- 8.3.2 Niksan Pharmaceutical Business Overview
- 8.3.3 Niksan Pharmaceutical Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Niksan Pharmaceutical Anti-dementia Drugs Product Portfolio
- 8.3.5 Niksan Pharmaceutical Recent Developments
- 8.4 Pfizer Inc
- 8.4.1 Pfizer Inc Company Information
- 8.4.2 Pfizer Inc Business Overview
- 8.4.3 Pfizer Inc Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pfizer Inc Anti-dementia Drugs Product Portfolio
- 8.4.5 Pfizer Inc Recent Developments
- 8.5 Reddy's Laboratories
- 8.5.1 Reddy's Laboratories Company Information
- 8.5.2 Reddy's Laboratories Business Overview
- 8.5.3 Reddy's Laboratories Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Reddy's Laboratories Anti-dementia Drugs Product Portfolio
- 8.5.5 Reddy's Laboratories Recent Developments
- 8.6 Anhui Taienkang Pharmaceutical Co., Ltd.
- 8.6.1 Anhui Taienkang Pharmaceutical Co., Ltd. Company Information
- 8.6.2 Anhui Taienkang Pharmaceutical Co., Ltd. Business Overview
- 8.6.3 Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Anhui Taienkang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.6.5 Anhui Taienkang Pharmaceutical Co., Ltd. Recent Developments
- 8.7 Chengdu Tongde Pharmaceutical Co., Ltd.
- 8.7.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
- 8.7.2 Chengdu Tongde Pharmaceutical Co., Ltd. Business Overview
- 8.7.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.7.5 Chengdu Tongde Pharmaceutical Co., Ltd. Recent Developments
- 8.8 Disa Pharmaceutical Group Co., Ltd.
- 8.8.1 Disa Pharmaceutical Group Co., Ltd. Company Information
- 8.8.2 Disa Pharmaceutical Group Co., Ltd. Business Overview
- 8.8.3 Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Disa Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.8.5 Disa Pharmaceutical Group Co., Ltd. Recent Developments
- 8.9 Jiangsu Hausen Pharmaceutical Group Co., Ltd.
- 8.9.1 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Company Information
- 8.9.2 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Business Overview
- 8.9.3 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.9.5 Jiangsu Hausen Pharmaceutical Group Co., Ltd. Recent Developments
- 8.10 Jinri Pharmaceutical (China) Co., Ltd.
- 8.10.1 Jinri Pharmaceutical (China) Co., Ltd. Company Information
- 8.10.2 Jinri Pharmaceutical (China) Co., Ltd. Business Overview
- 8.10.3 Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Jinri Pharmaceutical (China) Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.10.5 Jinri Pharmaceutical (China) Co., Ltd. Recent Developments
- 8.11 Livzon Group Livzon Pharmaceutical Factory
- 8.11.1 Livzon Group Livzon Pharmaceutical Factory Company Information
- 8.11.2 Livzon Group Livzon Pharmaceutical Factory Business Overview
- 8.11.3 Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Livzon Group Livzon Pharmaceutical Factory Anti-dementia Drugs Product Portfolio
- 8.11.5 Livzon Group Livzon Pharmaceutical Factory Recent Developments
- 8.12 Shandong Luoxin Pharmaceutical Group Co., Ltd.
- 8.12.1 Shandong Luoxin Pharmaceutical Group Co., Ltd. Company Information
- 8.12.2 Shandong Luoxin Pharmaceutical Group Co., Ltd. Business Overview
- 8.12.3 Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Shandong Luoxin Pharmaceutical Group Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.12.5 Shandong Luoxin Pharmaceutical Group Co., Ltd. Recent Developments
- 8.13 Shaoxing Jingxin Pharmaceutical Co., Ltd.
- 8.13.1 Shaoxing Jingxin Pharmaceutical Co., Ltd. Company Information
- 8.13.2 Shaoxing Jingxin Pharmaceutical Co., Ltd. Business Overview
- 8.13.3 Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Shaoxing Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.13.5 Shaoxing Jingxin Pharmaceutical Co., Ltd. Recent Developments
- 8.14 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.
- 8.14.1 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Company Information
- 8.14.2 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Business Overview
- 8.14.3 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.14.5 Shijiazhuang Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd. Recent Developments
- 8.15 Sichuan Xinston Pharmaceutical Co., Ltd.
- 8.15.1 Sichuan Xinston Pharmaceutical Co., Ltd. Company Information
- 8.15.2 Sichuan Xinston Pharmaceutical Co., Ltd. Business Overview
- 8.15.3 Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Sichuan Xinston Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.15.5 Sichuan Xinston Pharmaceutical Co., Ltd. Recent Developments
- 8.16 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd.
- 8.16.1 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Company Information
- 8.16.2 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Business Overview
- 8.16.3 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.16.5 Wanquan Wante Pharmaceutical Jiangsu Co., Ltd. Recent Developments
- 8.17 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd.
- 8.17.1 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Company Information
- 8.17.2 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Business Overview
- 8.17.3 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.17.5 Yichang Dongyangguang Changjiang Pharmaceutical Co., Ltd. Recent Developments
- 8.18 Yueyang Xinhuada Pharmaceutical Co., Ltd.
- 8.18.1 Yueyang Xinhuada Pharmaceutical Co., Ltd. Company Information
- 8.18.2 Yueyang Xinhuada Pharmaceutical Co., Ltd. Business Overview
- 8.18.3 Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Yueyang Xinhuada Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.18.5 Yueyang Xinhuada Pharmaceutical Co., Ltd. Recent Developments
- 8.19 Zhejiang Hisun Pharmaceutical Co., Ltd.
- 8.19.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
- 8.19.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
- 8.19.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.19.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
- 8.20 Zhejiang Huahai Pharmaceutical Co., Ltd.
- 8.20.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
- 8.20.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Business Overview
- 8.20.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.20.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments
- 8.21 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd.
- 8.21.1 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Company Information
- 8.21.2 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Business Overview
- 8.21.3 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.21.4 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.21.5 Zhejiang Jinhua Kangenbei Biopharmaceutical Co., Ltd. Recent Developments
- 8.22 Zhejiang Jingxin Pharmaceutical Co., Ltd.
- 8.22.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
- 8.22.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview
- 8.22.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.22.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.22.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments
- 8.23 Zhejiang Yixin Pharmaceutical Co., Ltd.
- 8.23.1 Zhejiang Yixin Pharmaceutical Co., Ltd. Company Information
- 8.23.2 Zhejiang Yixin Pharmaceutical Co., Ltd. Business Overview
- 8.23.3 Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.23.4 Zhejiang Yixin Pharmaceutical Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.23.5 Zhejiang Yixin Pharmaceutical Co., Ltd. Recent Developments
- 8.24 Zhien Biotechnology Co., Ltd.
- 8.24.1 Zhien Biotechnology Co., Ltd. Company Information
- 8.24.2 Zhien Biotechnology Co., Ltd. Business Overview
- 8.24.3 Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.24.4 Zhien Biotechnology Co., Ltd. Anti-dementia Drugs Product Portfolio
- 8.24.5 Zhien Biotechnology Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Anti-dementia Drugs Value Chain Analysis
- 9.1.1 Anti-dementia Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Anti-dementia Drugs Production Mode & Process
- 9.2 Anti-dementia Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Anti-dementia Drugs Distributors
- 9.2.3 Anti-dementia Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst